Literature DB >> 16116942

Neurocognitive correlates of recovery from schizophrenia.

Alex Kopelowicz1, Robert P Liberman, Joseph Ventura, Roberto Zarate, Jim Mintz.   

Abstract

UNLABELLED: BACKGROUND. Evidence has mounted that some patients with schizophrenia experience remission of symptoms and restoration of social and vocational functioning. The purpose of this study was to identify neurocognitive variables associated with recovery from schizophrenia.
METHOD: Twenty-eight patients diagnosed with DSM-IV schizophrenia or schizoaffective disorder and who met our operational definition of recovery from schizophrenia underwent a battery of neurocognitive tests. These subjects were matched with schizophrenia patients who did not meet recovery criteria ('non-recovered') and with normal controls.
RESULTS: On tests of executive functioning, verbal fluency and verbal working memory, recovered subjects performed significantly better than non-recovered subjects and were comparable to normal controls. Patient groups did not differ on a test that assessed early visual processing, but both groups performed significantly worse than normal controls.
CONCLUSIONS: Three measures of frontal lobe functioning appear to be neurocognitive domains associated with recovery from schizophrenia. These findings help narrow the search for targets for cognitive remediation that may have implications for improving community functioning.

Entities:  

Mesh:

Year:  2005        PMID: 16116942     DOI: 10.1017/s0033291705004575

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  14 in total

Review 1.  Determinants of functioning and well-being among individuals with schizophrenia: an integrated model.

Authors:  P T Yanos; R H Moos
Journal:  Clin Psychol Rev       Date:  2006-02-09

2.  Remission in schizophrenia: the relationship to baseline symptoms and changes in symptom domains during a one-year study.

Authors:  D L Kelly; E Weiner; M P Ball; R P McMahon; W T Carpenter; R W Buchanan
Journal:  J Psychopharmacol       Date:  2008-06-26       Impact factor: 4.153

3.  One-year randomized controlled trial and follow-up of integrated neurocognitive therapy for schizophrenia outpatients.

Authors:  Daniel R Mueller; Stefanie J Schmidt; Volker Roder
Journal:  Schizophr Bull       Date:  2015-02-22       Impact factor: 9.306

4.  Recovery from schizophrenia: form follows functioning.

Authors:  Robert P Liberman
Journal:  World Psychiatry       Date:  2012-10       Impact factor: 49.548

5.  Is personal recovery in schizophrenia predicted by low cognitive insight?

Authors:  Laura Giusti; Donatella Ussorio; Adele Tosone; Chiara Di Venanzio; Valeria Bianchini; Stefano Necozione; Massimo Casacchia; Rita Roncone
Journal:  Community Ment Health J       Date:  2014-07-27

6.  From perception to functional outcome in schizophrenia: modeling the role of ability and motivation.

Authors:  Michael F Green; Gerhard Hellemann; William P Horan; Junghee Lee; Jonathan K Wynn
Journal:  Arch Gen Psychiatry       Date:  2012-12

Review 7.  The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes.

Authors:  Raquel E Gur; Monica E Calkins; Ruben C Gur; William P Horan; Keith H Nuechterlein; Larry J Seidman; William S Stone
Journal:  Schizophr Bull       Date:  2006-11-13       Impact factor: 9.306

8.  "An Old Way to Solve an Old Problem": Provider Perspectives on Recovery-Oriented Services and Consumer Capabilities in New Mexico.

Authors:  Marnie K Watson; Caroline A Bonham; Cathleen E Willging; Richard L Hough
Journal:  Hum Organ       Date:  2011

9.  What matters: Factors impacting the recovery process among outpatient mental health service users.

Authors:  Suzanne Garverich; Christopher G Prener; Margaret E Guyer; Alisa K Lincoln
Journal:  Psychiatr Rehabil J       Date:  2020-04-09

10.  Neurophyisological and neurocognitive endophenotypes for schizophrenia genetics research.

Authors:  Yeon Ho Joo
Journal:  Psychiatry Investig       Date:  2008-12-31       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.